RecruitingNCT05945602

Neurophysiologic Biomarkers for Cognitive Rehabilitation

Optimization of Neurophysiologic Biomarkers for Rehabilitation Interventions in Veterans With Chronic Psychosis


Sponsor

VA Office of Research and Development

Enrollment

80 participants

Start Date

Oct 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Cognitive symptoms of schizophrenia interfere with daily life-from managing self-care, to more complex tasks like taking medications and living independently. Unfortunately, these cognitive symptoms are not corrected by 'standard of care' treatments (antipsychotic medications), although some schizophrenia patients may experience modest clinical and cognitive benefits from cognitive remediation. To enhance the clinical impact of cognitive remediation and other rehabilitative interventions for Veterans living with chronic psychosis, this study will develop novel brain-based tools to help identify those Veterans who are most likely to benefit from pro-cognitive therapies. These studies may advance predictive algorithms that improve functional outcomes and life quality in Veterans with schizophrenia.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

  • Have a DSM-5 diagnosis of a chronic psychotic disorder (e.g., schizophrenia, schizoaffective disorder, or delusional disorder); or b) are in good general mental and physical health (i.e., no active mental health condition).
  • Fluent in spoken and written English.
  • No impairment in hearing or vision.

Exclusion Criteria4

  • Active substance other than cannabis within the last 30 days as determined by self-report or positive urine toxicology (obtained as part of the screening process).
  • History of significant medical or neurological illness or intellectual disability.
  • Inability to comprehend or provide informed consent.
  • Specific to healthy comparison subjects: past or present diagnosis of schizophrenia, schizoaffective disorder, or other chronic psychotic disorder.

Interventions

OTHERNeurophysiologic Biomarker Assessments

Non-invasive electroencephalography will be recorded to derive neurophysiologic biomarkers.


Locations(1)

VA San Diego Healthcare System, San Diego, CA

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05945602


Related Trials